Vadimezan (Standard)

Overview

Vadimezan (Standard) (DMXAA (Standard)) is the analytical standard of Vadimezan ( HY-10964 ). This product is intended for research and analytical applications. Vadimezan (DMXAA; ASA-404), the tumor vascular disrupting agent (tumor-VDA), is a murine agonist of the stimulator of interferon genes ( STING ) and also a potent inducer of type I IFNs and other cytokines. Vadimezan is unable to activate human STING . Vadimezan has anti-influenza virus H1N1-PR8 activities.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Others | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > STING | Products > Signaling Pathways > IFNAR | Products > Signaling Pathways > Influenza Virus | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-10964R
• CAS No.: 117570-53-3
• Molecular Formula: C17H14O4
• Molecular Weight: 282.29
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source